Skip to main content
. 2024 Feb 5;16(3):678. doi: 10.3390/cancers16030678
4-HT 4-Hydroxytamoxifen
BC Breast cancer
ER Estrogen receptor
FBS Fetal bovine serum
HER2-E HER2-enriched
HR Hormone receptor
IHC Immunohistochemistry
PLN Positive lymph node
PMA Phorbol 12-myristate 13-acetate
PR Progesterone receptor
TAM Tumor-associated macrophage
TME Tumor microenvironment
TNBC Triple-negative breast cancer